Harpoon Therapeutics, Inc. announced that on April 14, 2020, Mr. Robbins was appointed to the Audit Committee of the Board (the Audit Committee) and the Compensation Committee of the Board (the Compensation Committee), and Dr. Bailes was appointed to the Nominating and Corporate Governance Committee of the Board (the Nominating Committee). As a result of these appointments and other committee-membership changes approved by the Board, the Audit Committee is now comprised of Ms. Eastland and Messrs. Myers and Robbins, the Compensation Committee is now comprised of Messrs. Evnin, Hunt, Myers and Robbins, and the Nominating Committee is now comprised of Ms. Eastland and Messrs. Bailes, Drachman and Myers. The Board also appointed Mr. Hunt as Chairman of the Board.